Maple Rock Capital Partners Inc. Has $123.93 Million Stock Holdings in CVS Health Corporation $CVS

Maple Rock Capital Partners Inc. raised its stake in CVS Health Corporation (NYSE:CVS) by 14.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,197,996 shares of the pharmacy operator’s stock after purchasing an additional 149,896 shares during the period. CVS Health accounts for 2.5% of Maple Rock Capital Partners Inc.’s holdings, making the stock its 13th biggest holding. Maple Rock Capital Partners Inc.’s holdings in CVS Health were worth $123,933,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd increased its position in CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares in the last quarter. Swiss RE Ltd. acquired a new position in CVS Health during the 4th quarter worth approximately $26,000. Kilter Group LLC bought a new position in CVS Health in the second quarter worth approximately $27,000. Sankala Group LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Finally, Global Trust Asset Management LLC increased its holdings in shares of CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 300 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. Cantor Fitzgerald increased their target price on CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, July 7th. Robert W. Baird set a $107.00 price target on shares of CVS Health in a research note on Thursday, August 6th. Mizuho raised their price objective on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. HSBC reiterated a “hold” rating and set a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Finally, Royal Bank Of Canada boosted their target price on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Performance

Shares of CVS stock opened at $94.02 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The firm has a 50-day moving average of $101.27 and a 200-day moving average of $89.68. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a market cap of $120.25 billion, a P/E ratio of 24.87, a P/E/G ratio of 0.91 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the prior year, the firm posted $1.81 EPS. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s payout ratio is currently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.